Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Corvus Pharmaceuticals stock
Learn how to easily invest in Corvus Pharmaceuticals stock.
Corvus Pharmaceuticals Inc is a biotechnology business based in the US. Corvus Pharmaceuticals shares (CRVS) are listed on the NASDAQ and all prices are listed in US Dollars. Corvus Pharmaceuticals employs 28 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Corvus Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CRVS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Corvus Pharmaceuticals stock price (NASDAQ: CRVS)Use our graph to track the performance of CRVS stocks over time.
Corvus Pharmaceuticals shares at a glance
|Latest market close||$0.74|
|52-week range||$0.75 - $9.54|
|50-day moving average||$0.98|
|200-day moving average||$1.52|
|Wall St. target price||$4.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.89|
Buy Corvus Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Corvus Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Corvus Pharmaceuticals price performance over time
|1 week (2022-09-16)||-19.77%|
|1 month (2022-08-25)||-28.85%|
|3 months (2022-06-24)||-14.94%|
|6 months (2022-03-24)||-55.42%|
|1 year (2021-09-24)||-89.12%|
|2 years (2020-09-25)||-81.55%|
|3 years (2019-09-25)||3.28|
|5 years (2017-09-25)||16.05|
Corvus Pharmaceuticals financials
|Gross profit TTM||$0|
|Return on assets TTM||-18.42%|
|Return on equity TTM||-41.37%|
|Market capitalisation||$42.9 million|
TTM: trailing 12 months
Corvus Pharmaceuticals share dividends
We're not expecting Corvus Pharmaceuticals to pay a dividend over the next 12 months.
Corvus Pharmaceuticals share price volatility
Over the last 12 months, Corvus Pharmaceuticals's shares have ranged in value from as little as $0.75 up to $9.54. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Corvus Pharmaceuticals's is 0.8961. This would suggest that Corvus Pharmaceuticals's shares are less volatile than average (for this exchange).
Corvus Pharmaceuticals overview
Corvus Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The company also develops CPI-818, a covalent inhibitor of ITK, which is in Phase I/Ib clinical trial to treat patients with various malignant T-cell lymphomas, as well as designed to inhibit the proliferation of certain malignant T-cells; and Ciforadenant (CPI-444), an oral, small molecule antagonist of the A2A receptor that is in Phase II clinical trial for patients with either advanced or refractory renal cell cancer. Its preclinical stage products include CPI-182, an antibody designed to block inflammation and myeloid suppression; and CPI-935, an adenosine A2B receptor antagonist to prevent fibrosis. Corvus Pharmaceuticals, Inc. has a strategic collaboration with Angel Pharmaceuticals for the development its pipeline of targeted investigational medicines.
Corvus Pharmaceuticals in the news
Corvus Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Frequently asked questionsWhat percentage of Corvus Pharmaceuticals is owned by insiders or institutions?
Currently 3.719% of Corvus Pharmaceuticals shares are held by insiders and 55.359% by institutions. How many people work for Corvus Pharmaceuticals?
Latest data suggests 28 work at Corvus Pharmaceuticals. When does the fiscal year end for Corvus Pharmaceuticals?
Corvus Pharmaceuticals's fiscal year ends in December. Where is Corvus Pharmaceuticals based?
Corvus Pharmaceuticals's address is: 863 Mitten Road, Burlingame, CA, United States, 94010 What is Corvus Pharmaceuticals's ISIN number?
Corvus Pharmaceuticals's international securities identification number is: US2210151005 What is Corvus Pharmaceuticals's CUSIP number?
Corvus Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 221015100
More guides on Finder
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.
Ask an Expert